Study explores intratumoral microbiota as a novel frontier in cancer research

Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.

Centessa 2.0 with a twist: Medicxi combines six immuno-derm startups with $100M

European biotech investor Medicxi is bringing six startups under one roof to form an immuno-dermatology drugmaker with 14 pipeline projects in a move reminiscent of

February 12, 2024

Emergent calls on new CEO Joe Papa to lead turnaround following pandemic stumbles

Joe Papa is known for putting himself in a pickle. He’s made a career out of turnaround attempts, most recently at embattled Valeant Pharmaceuticals. Next

February 22, 2024

Vendor Sprawl: The Hidden Barrier to Effective Patient Engagement

Aditya Bansod, Chief Technology Officer, Luma Health Patient engagement is a critical priority for modern healthcare organizations. Yet, the path is often obstructed by the

July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.